Does a Surrogate Share DNA With the Baby?

No — not in the sense the question is asking. In gestational surrogacy, which is the standard model in US practice today, none of the baby’s inherited DNA comes from you. The embryo is created in a lab before it ever reaches your body, using an egg from the intended mother or an egg donor and sperm from the intended father or a sperm donor. Your eggs are never used, so you are not a genetic parent of the child you carry.

That’s the answer nearly everyone is looking for, and it holds. It just needs one word of precision: inherited. Small numbers of cells — and therefore DNA — do cross in both directions during pregnancy, a documented phenomenon called microchimerism. It isn’t inheritance, and it doesn’t make you a genetic parent. But “zero DNA, full stop” isn’t quite what the science says, and you deserve the accurate version rather than the tidy one.

Almost everyone who asks this has four or five follow-ups right behind it: What about blood? What about the placenta? Could the baby look like me? Doesn’t something pass between us over nine months? Those are fair questions, and the honest answers are more interesting than a flat “no.” Here’s the whole picture.

Key Takeaways

• A gestational surrogate passes on no inherited DNA. The baby’s inherited genome comes from the egg and the sperm used to create the embryo — never from the carrier.
• That inherited code is set at fertilization, days or years before transfer. The honest caveat: cells acquire new mutations every time they divide, so some genetic variation arises in the embryo itself afterward. None of it comes from you.
• Your circulation and the baby’s stay separate. The placenta is an exchange surface, not a shared bloodstream. Blood-type compatibility is not a matching criterion; Rh factor is the one item your OB actively manages.
• Your health during pregnancy genuinely affects how the baby grows — that’s ordinary obstetrics. Research on the prenatal environment and gene expression is real but far less settled, and neither one rewrites the DNA sequence.
• Small numbers of cells cross both ways in pregnancy (microchimerism). It’s real, it isn’t specific to surrogacy, and it is neither inheritance nor a basis for parentage.
• Traditional surrogacy — where the surrogate’s own egg is used — is the real exception. ASRM describes it as uncommon in current US practice and as raising legal and ethical questions distinct from gestational arrangements.

The baby’s inherited DNA is set before the embryo reaches you

Here’s the sequence that makes this so clear-cut. An egg is retrieved from the intended mother or an egg donor. It’s fertilized in the lab with sperm from the intended father or a sperm donor. The resulting embryo is commonly grown for about five to six days to the blastocyst stage — a few hundred cells, still smaller than a grain of salt — and then frozen for a later transfer. That’s the usual pattern in gestational surrogacy, not a universal rule: some cycles transfer earlier, some use fresh rather than frozen embryos. Ask your clinic which applies to your cycle. It affects your calendar, not the genetics.

Genetic testing of the embryo is optional, not a standard step. When a clinic does it, a few cells are biopsied from the embryo and the embryo is typically frozen while the lab runs the analysis — the results come back days later, not during the procedure. It’s also worth knowing that ASRM’s committee opinion on preimplantation genetic testing for aneuploidy concludes the benefit of routine PGT-A has not been demonstrated for all IVF patients. Whether it happens is the intended parents’ decision with their clinic, and it doesn’t change your role either way.

The inherited code — everything passed down from the two people who provided the egg and sperm — was determined at fertilization, in a dish, before you were anywhere in the picture. Two caveats keep that statement accurate rather than merely satisfying. First, cells pick up new mutations as they divide, and some arise after fertilization, which is why embryos and people can be mosaic — carrying more than one cell line. Those changes originate in the embryo’s own dividing cells, not in the person carrying the pregnancy. Second, DNA isn’t the whole story for every trait: adult height, for example, reflects genetics and nutrition and health across development. The genome sets the range, not every outcome.

The transfer itself is a short outpatient procedure in which the embryo is placed into your uterus through a thin catheter, usually without anesthesia. It doesn’t mix anything. It doesn’t add anything. If you want to see how uneventful the actual mechanics are, our guide on what to expect at embryo transfer walks through the day step by step.

This is also why some intended parents use both a donor egg and donor sperm. In those cases the baby isn’t genetically related to either intended parent — and they can still be that child’s legal parents. That particular combination is the one place where genetics touches the legal side of your journey, and it’s covered further down.

Do you share blood with the baby?

Not in the way people usually picture — and the real answer has one more wrinkle than the standard reassurance.

Your circulatory system and the baby’s are separate systems. They don’t join. What connects them is the placenta, which works like an exchange surface: your blood flows on one side, the baby’s blood flows on the other, and specific things pass across the barrier between them. Oxygen and nutrients go to the baby. Carbon dioxide and waste come back to you. Protective antibodies cross to the baby, mostly in the third trimester. So do alcohol, nicotine, certain infections, and many medications — placental transfer is selective and substance-specific, which is why medication questions get answered drug by drug by your clinician rather than by one blanket rule. Our guide to surrogacy medications covers what a typical protocol involves.

What doesn’t happen is a shared bloodstream. What can happen, usually in very small amounts, is fetomaternal hemorrhage: some fetal blood crossing into your circulation, most often around delivery, and sometimes after bleeding, abdominal trauma, or a procedure like amniocentesis or CVS. In most pregnancies the volume is tiny and clinically silent. It matters for one specific reason, and that reason is Rh factor.

If you’re Rh-negative and the fetus is Rh-positive, that crossing can sensitize your immune system to make antibodies against Rh-positive blood. Sensitization rarely causes trouble in the current pregnancy, but in a later Rh-positive pregnancy those antibodies can cross the placenta and destroy fetal red blood cells — hemolytic disease of the fetus and newborn, which can be serious. That’s the problem Rh immune globulin (RhIg, often called RhoGAM) exists to prevent, and it isn’t a reflex handed out to every Rh-negative woman. As ACOG explains, whether and when you receive it depends on your antibody screen (it doesn’t help someone who is already sensitized), on the fetus’s or newborn’s Rh status, and on whether a potentially sensitizing event has occurred. A common pattern is a dose around 28 weeks, another after a sensitizing event, and another after delivery if the newborn is Rh-positive — but your OB builds that plan from your test results, not from a script.

One practical note specific to surrogacy: your fertility clinic types your blood during screening, but by the time a 28-week dose would be due you’ll have been released to your OB or prenatal provider. Ask at your first prenatal visit that your Rh status and antibody screen carried over correctly from the clinic’s records.

Ordinary ABO differences are a separate matter. You and the baby can have entirely different blood types, and nobody screens surrogates for blood-type compatibility with an embryo — it isn’t a matching criterion. ABO incompatibility can contribute to newborn jaundice, which pediatricians manage as routine newborn care. It isn’t a reason a match doesn’t work.

The placenta deserves one correction to how it’s usually described. The part doing the exchanging — the villi, the trophoblast, the fetal vessels — grows from the embryo’s cells and carries the baby’s DNA, not yours. But the placenta isn’t purely fetal. It forms at an interface, and its maternal side, the decidua, is your uterine lining transformed for pregnancy; placental physiology references describe both components. So the organ is a joint structure: fetal tissue doing the exchange, anchored in maternal tissue supplying the blood. Neither half rewrites the other’s genome.

What your body does influence — and what that isn’t

This is where the honest answer gets more nuanced than “you’re just an incubator” — a phrase we’d retire if we could, because it isn’t accurate and it isn’t fair to what you’re doing.

Two very different claims usually get mashed together here. Take them one at a time, because they carry different amounts of evidence.

The clinical part is well established and not exotic. How a pregnancy goes affects how the fetus grows and how the birth goes. Nutrition, blood pressure, blood sugar, infection, smoking, and alcohol all have measurable effects on fetal growth and on birth outcomes like gestational age and birth weight. That is ordinary obstetrics, it’s the entire reason prenatal care exists, and it’s a large part of what you’re actually being asked to do well. It says nothing about anyone’s DNA.

The epigenetic part is a real research field with much looser conclusions. Epigenetic marks — chemical tags such as DNA methylation that sit on top of the sequence and influence which genes are switched on — can be affected by conditions before birth. The most-cited human example is the Dutch Hunger Winter: adults who were conceived during the 1944–45 famine showed persistent differences in DNA methylation at a growth-related gene roughly six decades later, compared with their unexposed same-sex siblings. Read what that is and isn’t. It is an observational finding, in a severe famine, measuring a chemical mark — not a demonstration that ordinary variation within a healthy, well-managed pregnancy shapes any particular trait. This work has not been done in surrogacy specifically, and anyone quoting you precise effects on a child’s personality, intelligence, or appearance is far past the evidence.

What both parts share is the same ceiling. Growing a fetus well, or turning a gene’s activity up or down, is not the same as writing the gene. Your health during the pregnancy matters enormously. It still isn’t inheritance.

Microchimerism: the honest footnote

If you dig into this online, you’ll eventually find the word microchimerism, usually presented in a slightly ominous way. Here’s the straight version.

In pregnancy, a small number of fetal cells cross into the pregnant person’s bloodstream, and a small number of the pregnant person’s cells cross the other way. Some persist — fetal cells have been detected in women decades after they gave birth. Reviews of maternal–fetal cellular trafficking describe both directions. It appears to be a common feature of pregnancy rather than a rare accident, though how many cells cross varies, detection methods differ between studies, and the phrase “every pregnancy, always” is shorthand rather than a measured fact.

What it means for surrogacy is limited, and worth stating precisely instead of absolutely:

• It isn’t inheritance. Inheritance means the genome the embryo was built from, and that was fixed at fertilization. Microchimeric cells arrive afterward, carry their own separate genome, and are not part of the baby’s inherited genome. Nothing about them makes a carrier a genetic parent.
• It isn’t what a relationship DNA test measures. Standard parentage and relationship testing reads inherited genotypes from a bulk sample. Microchimeric cells are typically present at a tiny fraction of a percent of the cells in a sample — orders of magnitude below what those tests are built to detect or report. Finding microchimerism at all requires specialized assays designed for that purpose. That is a statement about what these two kinds of testing are designed to do, not a claim that a lab has run the surrogacy version of the experiment.
• Legal parentage in the US runs on statute and court process, not cell counts. Parentage is established by the mechanisms described below — not by any measure of biological material moving between two people. We haven’t found a US case in which microchimerism was raised as a basis for a parentage claim, which is not the same as certifying that none exists anywhere. Your own attorney is the one who answers this for your arrangement.

The long-term health significance of microchimerism is still being researched and isn’t well established in either direction. It’s a real biological phenomenon and a genuinely interesting one — but it is not a hidden genetic connection, and anyone framing it that way is overselling it.

”Is the baby related to me?”

Sometimes the question underneath the question isn’t scientific. It’s what am I to this child?

Genetically, the answer stays no. You’re not the baby’s biological mother in the sense that word usually carries. Many surrogates land on language like “I carried them, I didn’t make them,” and find that it fits. Others don’t need language for it at all.

We’re not going to tell you how it will feel — that varies, and any article confidently reporting what “most surrogates feel” is guessing rather than citing anything. What we can point to is the support structure that professional guidance says should exist around this question: ASRM’s ethics opinion on gestational carriers recommends psychological evaluation before a carrier is matched and access to counseling during and after the journey. A recommendation isn’t proof every program delivers it, so ask directly — is there counseling after delivery as well as during, who provides it, and who pays. Our guide to surrogate mental health covers what that support looks like in practice.

Your own kids will ask, too, usually in the bluntest terms available. Our guide on explaining surrogacy to your children has age-appropriate scripts, and “the baby’s family made the baby, my tummy is just the safest place for it to grow” holds up remarkably well with a five-year-old.

The one exception: traditional surrogacy

Everything above describes gestational surrogacy, and the line between the two models is purely genetic. In traditional surrogacy, the surrogate’s own egg is used — so she is the baby’s genetic mother. That is the one arrangement in which the answer to this article’s question flips to yes, and it’s the only reason traditional surrogacy appears here at all.

It’s the older model, and it has become uncommon in the United States. ASRM’s policy overview of gestational carriers describes traditional arrangements as rarely used in current practice and as raising legal and ethical questions distinct from gestational carrier arrangements. We don’t have reliable national figures on how many programs decline to facilitate it, so treat any article handing you a hard percentage with suspicion.

The genetic link is what changes the analysis: many state surrogacy statutes were written around gestational arrangements specifically, which can leave traditional surrogacy in murkier territory or outside the statute altogether. Everything else about the comparison — screening, cost, how matching differs — is in our guide to the differences between gestational and traditional surrogacy.

If you’re being recruited for anything involving your own eggs, slow down and get an attorney who practices reproductive law in your state before signing anything.

What your DNA does and doesn’t do legally

The short version, because surrogate parental rights and our surrogacy laws by state guide cover the full machinery: in gestational surrogacy, legal parentage comes from a legal process — a qualifying gestational carrier agreement in some states, a pre-birth or post-birth court order in others — and not from a genetic test. Your lack of a genetic link to the child is generally a helpful fact in every one of those routes, but it is not the mechanism that makes anyone a parent.

There is one place where genetics genuinely bites, and it’s on the intended parents’ side rather than yours. Some states condition their friendlier statutes or procedures on at least one intended parent being genetically related to the child — which is precisely the situation a double-donor embryo runs into. If the embryo you’d be carrying was created from both a donor egg and donor sperm, that is the question to put to your attorney, about the state where you’ll actually deliver, before you sign.

Which is the other thing to pin down: that you have your own attorney, separate from the intended parents’ counsel. Independent legal representation for the carrier is recommended by ASRM’s committee opinion on practices using gestational carriers, and intended parents commonly pay for it — commonly is not the same as guaranteed, so get it in writing.

Frequently Asked Questions

Could the baby end up looking like me?

Not because of you. The baby’s appearance is shaped by inherited genes from the egg and sperm providers. Coincidental resemblance happens — people constantly tell new parents their baby has someone’s nose — but there’s no biological pathway for your features to transfer.

Would a DNA test show any relationship between us?

No. A standard paternity or relationship DNA test would show no parent–child relationship between a gestational carrier and the baby she delivered. Two practical notes. A test can only “match” a child to an egg or sperm provider if that person’s sample is available for comparison, or if a relative surfaces in a consumer database. And if you’re carrying for a relative, see the last question below.

What about NIPT — doesn’t that test read the baby’s DNA from my blood?

It reads a mixture, and the distinction matters. Your plasma during pregnancy contains your own cell-free DNA plus cell-free DNA shed by the placenta, and prenatal cell-free DNA screening analyzes that combined pool. The placental fraction usually reflects the fetus — but not always. In confined placental mosaicism, the placenta carries a chromosomal makeup the fetus does not, one documented reason NIPT results can be discordant with the baby’s actual genetics. Your own DNA in the sample can influence results too. That’s why NIPT is a screening test rather than a diagnosis: a high-risk result calls for diagnostic testing, such as CVS or amniocentesis, before anyone draws conclusions.

One point of authority is worth being explicit about, because it gets described wrongly: you are the patient. It’s your blood, your prenatal provider orders it, and it happens with your consent — intended parents can’t order testing on you. ASRM’s ethics opinion on gestational carriers treats the carrier’s authority over her own medical care as a baseline feature of a properly run arrangement. What contracts do address is which screening the parties expect during the pregnancy and who pays for it, so read that section before you sign and raise any disagreement then rather than at twelve weeks. When screening is done, the lab should be told it’s a gestational carrier pregnancy and whether donor gametes were used — it changes how some results are interpreted — and a genetic counselor is the right person to walk everyone through an unexpected result.

Do the surrogate and baby need to have the same blood type?

No. Blood-type compatibility is not a matching criterion and doesn’t come up in screening for that reason. Your Rh status and antibody screen are checked as part of routine prenatal care, and if you’re Rh-negative your OB manages Rh immune globulin based on those results, the fetus’s or newborn’s Rh status, and any sensitizing events — not on a fixed script.

Will my own children be genetically related to the baby?

No — with one caveat worth naming. Your children share DNA with you, and you pass none of your inherited DNA to the baby you carry, so there’s no genetic relationship between your kids and that child: not half-siblings, not cousins, not related at all. The caveat is intrafamilial arrangements. If you carry for your sister and her egg is used, the child is your genetic niece or nephew and your children are that child’s cousins — through your shared ancestry with your sister, not through the pregnancy. You’d be exactly that related if someone else had carried.

This question comes up often with older children who have worked out how family trees function and want to know where this baby fits. In a standard gestational journey, the answer is that the baby belongs to a different tree entirely.

About this guide

Every clinical and legal claim above is sourced to published guidance from ASRM and ACOG, to NHGRI’s genetics glossary, or to peer-reviewed literature — all linked at the point the claim is made and listed again below. Where the underlying evidence supports a hedge rather than a conclusion, we’ve written the hedge rather than rounding it up.

This article has not been reviewed by a named clinician or attorney, and we won’t pretend otherwise. That’s exactly why it routes you to a person for anything that turns on your specific situation:

• Rh status, your antibody screen, and Rh immune globulin timing — your OB or prenatal provider. Raise it at your first prenatal visit, when the handoff from the fertility clinic happens.
• NIPT and any unexpected screening result — your prenatal provider, plus a genetic counselor for interpretation.
• Which embryo is being transferred, and whether it was genetically tested — the fertility clinic running your cycle.
• Parentage, your contract, donor gametes, or anything involving your own eggs — your own attorney, licensed in the state where you’ll deliver, separate from the intended parents’ counsel.

General information, not medical or legal advice. Reviewed against the sources below as of the date at the top of this page.

Sources

• ASRM, Gestational Carrier Policy in the United States
• ASRM, Consideration of the Gestational Carrier (Ethics Committee Opinion, 2023)
• ASRM, Recommendations for Practices Using Gestational Carriers (Committee Opinion, 2022)
• ASRM, The Use of Preimplantation Genetic Testing for Aneuploidy (Committee Opinion, 2024)
• ACOG, The Rh Factor: How It Can Affect Your Pregnancy
• NHGRI, Mosaicism
• NCBI Bookshelf, Physiology, Placenta
• Review of maternal–fetal cellular trafficking and microchimerism
• Research on discordant noninvasive prenatal testing and confined placental mosaicism
• PNAS, Persistent epigenetic differences associated with prenatal exposure to famine in humans (2008)
• Massachusetts General Laws, c.209C §28G, parentage under a gestational carrier agreement